ESR1 and breast carcinoma: We next focused on six ER+ breast cancer datasets that we had previously analysed from the perspective of EMT and tamoxifen resistance driving each other in ER+ breast cancer [12]: GSE6532, GSE9195, GSE17705, GSE24202, GSE43495 and GSE67916.